More Than Half Of Physicians Admit To Changing Perceptions Of A Drug Due To Social Media

Social media can have as powerful an influence on physicians as they do on the public, according to a new survey conducted by Sermo and LiveWorld.

Of the 50-plus pharma marketers and 200-plus U.S. physicians surveyed, more than half (57%) of doctors said they frequently or occasionally change their initial perception of a medication due to social media.

The results also revealed social media’s strong influence on prescribing habits, ongoing medical education and professional networking.

On top of that, a whopping 94% of the pharma marketers interviewed said social media is an important HCP channel. So much so that 90% of marketers have social media in the 2023 budget.

Furthermore, of those marketers with social media in the budget, 50% report their social media spend will be up from the previous year, and no one reported a decrease in this budget.

Ninety-two percent of the surveyed pharma marketers agreed with physicians in the vital role that social media play in influencing clinical and treatment decisions.

So where are physicians spending their time on social media? Doctors’ top choices included closed-communities Doximity and Sermo for clinical and professional purposes.

In fact, 41% of doctors reported changing their views on a medication based on content on Sermo and 33% based on content on Doximity. Physicians said they are more trusting and more likely to download information from closed-community groups as opposed to TikTok or Facebook.

However, doctors are using public social media platforms as well. A little more than half are on private group Facebook pages; 35% said they are getting congressional announcements and presentations from LinkedIn; and 62% reported using Twitter to follow hospital and professional updates.

Physicians are also following other doctors and HCP influencers on social platforms. The group follows influencers based on their credentials (27%), their knowledge of a topic (26%) and their relatable content (26%). Seeing the value in influencers, 56% of pharma markers said they would include digital influencers in their 2023 plans.

“Social media is a serious and necessary factor in HCP marketing and promotion. Social media is being widely adopted, budgeted and planned for in 2023. Marketers have faith in its reach, persuasiveness, peer-to-peer credibility and immediacy,” said LiveWorld vice president of HCP strategy and survey author, Danny Flamberg, in a press release.

 

Source Link

Recommended Articles

New NFIB Survey: Small Businesses Report Reduced Optimism

The NFIB Small Business Optimism Index fell 0.6 points in May to 95.3, remaining below its 52-year average of 98.0. The Uncertainty Index rose 3 points from April to 91, remaining well above its historical average of 68. As reported in NFIB’s monthly Jobs Report, the NFIB Small Business Employment Index remained essentially flat, registering 100.3 in May. ...

Read More

Trump Announces TrumpRx Expansion, Adding 160 More Drugs

President Trump on Friday announced that over 100 prescription medications would be added to his administration’s direct-to-consumer drug platform, TrumpRx, the second expansion of the initiative in as many months. “I am pleased to announce that TrumpRx.gov is adding another 160 Prescription Drugs, at highly discounted prices, for a new total of over 800 of the most commonly-used Prescription Drugs,” ...

Read More

Skyrocketing GLP-1 Demand Creates Major Financial Strain For Employers

GLP-1 drugs are a double-edged sword for the nation’s employers. Although they are having a demonstrable effect on workplace health, the high cost is putting a strain on their budgets. GLP-1s, known by brand names such as Ozempic, Wegovy, Mounjaro or Zepbound, originally were developed to help regulate blood sugar in people with Type 2 ...

Read More

Judge Throws Out Policy Imposing $100,000 Fees for Skilled Worker Visas

A Trump administration initiative to impose $100,000 fees on employers seeking visas for skilled foreign workers amounts to an unlawful tax on those companies and must be voided “in its entirety,” a federal judge ruled on Monday. The decision by Judge Leo T. Sorokin of the Federal District Court for the District of Massachusetts nullified ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square